FIXX
Price
$0.93
Change
-$0.00 (-0.00%)
Updated
Mar 25, 6:59 PM EST
45 days until earnings call
MTEM
Price
$2.24
Change
-$0.11 (-4.68%)
Updated
Mar 28, 6:59 PM EST
Ad is loading...

Compare trend and price FIXX vs MTEM

Header iconFIXX vs MTEM Comparison
Open Charts FIXX vs MTEMBanner chart's image
Homology Medicines
Price$0.93
Change-$0.00 (-0.00%)
Volume$287.55K
CapitalizationN/A
Molecular Templates
Price$2.24
Change-$0.11 (-4.68%)
Volume$141.68K
CapitalizationN/A
View a ticker or compare two or three
FIXX vs MTEM Comparison Chart

Loading...

FIXXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
FIXX vs. MTEM commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIXX is a Hold and MTEM is a Hold.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (FIXX: $0.93 vs. MTEM: $2.24)
Brand notoriety: FIXX and MTEM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FIXX: 700% vs. MTEM: 1453%
Market capitalization -- FIXX: $53.92M vs. MTEM: $12.04M
FIXX [@Biotechnology] is valued at $53.92M. MTEM’s [@Biotechnology] market capitalization is $12.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $570.99B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FIXX’s FA Score shows that 1 FA rating(s) are green whileMTEM’s FA Score has 0 green FA rating(s).

  • FIXX’s FA Score: 1 green, 4 red.
  • MTEM’s FA Score: 0 green, 5 red.
According to our system of comparison, FIXX is a better buy in the long-term than MTEM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FIXX’s TA Score shows that 4 TA indicator(s) are bullish.

  • FIXX’s TA Score: 4 bullish, 5 bearish.

Price Growth

FIXX (@Biotechnology) experienced а -94.13% price change this week, while MTEM (@Biotechnology) price change was +24.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.

Reported Earning Dates

FIXX is expected to report earnings on May 13, 2024.

MTEM is expected to report earnings on Nov 13, 2023.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for FIXX with price predictions.
OPEN
A.I.dvisor published
a Summary for MTEM with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
FIXX($53.9M) has a higher market cap than MTEM($12M). MTEM YTD gains are higher at: -39.946 vs. FIXX (-91.459). MTEM has higher annual earnings (EBITDA): -14.9M vs. FIXX (-91.52M). MTEM has more cash in the bank: 15.8M vs. FIXX (19K). MTEM has less debt than FIXX: MTEM (12.8M) vs FIXX (28.3M). MTEM has higher revenues than FIXX: MTEM (48.6M) vs FIXX (1.16M).
FIXXMTEMFIXX / MTEM
Capitalization53.9M12M449%
EBITDA-91.52M-14.9M614%
Gain YTD-91.459-39.946229%
P/E RatioN/AN/A-
Revenue1.16M48.6M2%
Total Cash19K15.8M0%
Total Debt28.3M12.8M221%
FUNDAMENTALS RATINGS
FIXX vs MTEM: Fundamental Ratings
FIXX
MTEM
OUTLOOK RATING
1..100
7751
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
48
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
5095
P/E GROWTH RATING
1..100
10054
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FIXX's Valuation (9) in the Biotechnology industry is somewhat better than the same rating for MTEM (48). This means that FIXX’s stock grew somewhat faster than MTEM’s over the last 12 months.

FIXX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MTEM (100). This means that FIXX’s stock grew similarly to MTEM’s over the last 12 months.

FIXX's SMR Rating (98) in the Biotechnology industry is in the same range as MTEM (100). This means that FIXX’s stock grew similarly to MTEM’s over the last 12 months.

FIXX's Price Growth Rating (50) in the Biotechnology industry is somewhat better than the same rating for MTEM (95). This means that FIXX’s stock grew somewhat faster than MTEM’s over the last 12 months.

MTEM's P/E Growth Rating (54) in the Biotechnology industry is somewhat better than the same rating for FIXX (100). This means that MTEM’s stock grew somewhat faster than FIXX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FIXX
RSI
ODDS (%)
Bullish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
82%
Momentum
ODDS (%)
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
80%
Aroon
ODDS (%)
Bullish Trend 4 days ago
69%
View a ticker or compare two or three
Ad is loading...
FIXXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HQI13.090.02
+0.15%
HireQuest
RDWR18.72-0.07
-0.37%
Radware Ltd
ACVA18.76-0.10
-0.53%
ACV Auctions
PHG20.00-0.33
-1.62%
Koninklijke Philips NV
WRNT0.48-0.02
-3.21%
Warrantee

FIXX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FIXX has been closely correlated with GMDA. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if FIXX jumps, then GMDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FIXX
1D Price
Change %
FIXX100%
N/A
GMDA - FIXX
78%
Closely correlated
-39.19%
MDGL - FIXX
39%
Loosely correlated
+3.18%
AMPE - FIXX
38%
Loosely correlated
+12.20%
ARRY - FIXX
34%
Loosely correlated
-1.26%
AXON - FIXX
32%
Poorly correlated
-0.98%
More

MTEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTEM has been loosely correlated with GOSS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if MTEM jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTEM
1D Price
Change %
MTEM100%
-5.08%
GOSS - MTEM
39%
Loosely correlated
+0.43%
AVRO - MTEM
39%
Loosely correlated
+2.38%
AXON - MTEM
36%
Loosely correlated
-0.98%
CYTK - MTEM
34%
Loosely correlated
-1.82%
EIGR - MTEM
33%
Poorly correlated
+0.50%
More